Back

Ranolazine – mechanism and clinical results in AF.

20 June 2017 (11:22 - 11:45)
Organised by:
Congress Presentation Part of: Pharmacological therapy in AF Pharmacology EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Gaetano Maria De Ferrari

University of Turin, Turin (Italy)

3 More presentations in this session

Presentation thumbnail
The current role of Dronedarone.
Professor S. Hohnloser (Frankfurt, DE)
Slides Video
Presentation thumbnail
Atrial-specific antiarrhythmic agents.
Doctor S. Nattel (Montreal, CA)
Slides Video
Presentation thumbnail
Non anti arrhythmic pharmacological therapy for maintenance of sinus rhythm.
Doctor I. Savelieva (London, GB)
Slides Video

Access the full session

Session thumbnail
Pharmacological therapy in AF

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 11:22 CET
You may be interested in
thumbnail
Congress Presentation
The role of Ranolazine alone or in combination with a Class III anti-arrhythmic drug for DC cardioversion for persistent AF
7 April 2024
thumbnail
Congress Session
Young Investigator Award Basic and Translational Science
1 April 2025
thumbnail
Webinar
Current role of cardiovascular pharmacotherapy for arrhythmia management
9 December 2021
thumbnail
Congress Presentation
Ranolazine ameliorates palmitic acid-induced insulin resistance in HL-1 cardiomyocytes by Ca2+/ CaMKII modulation: an in vitro investigation and population-based cohort study
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources